| References |
|
|
Arrondel C,
Vodovar N,
Knebelmann B et al.
(2002)
Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndrome.
Journal of the American Society of Nephrology
13:
65–74.
|
|
|
Bekheirnia MR,
Reed B,
Gregory MC et al.
(2010)
Genotype–phenotype correlation in X-linked Alport syndrome.
Journal of the American Society of Nephrology
21:
876–883.
|
|
|
Ben-Bassat M,
Cohen L and
Rosenfeld J
(1971)
The glomerular basement membrane in the Nail–Patella syndrome.
Archives of Pathology
92:
350–355.
|
|
|
Berheim J,
Dechavanne M and
Bryon PA
(1976)
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness.
American Journal of Medicine
61:
145–150.
|
|
|
Bhatt A,
Broxson E,
Witte D and
Omoloja A
(2009)
Thrombocytopenia and proteinuria. Nonmuscle myosin heavy-chain-9-related disease (MYH9 RD) or Epstein syndrome (ES).
Pediatric Nephrology
24:
485–488.
|
|
|
Bongers EM,
Gubler MC and
Knoers NV
(2002)
Nail–Patella syndrome. Overview on clinical and molecular findings.
Pediatric Nephrology
17:
703–712.
|
|
|
Bongers EM,
Huysmans FT,
Levtchenko E et al.
(2005)
Genotype–phenotype studies in Nail–Patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy.
European Journal of Human Genetics
13:
935–946.
|
|
|
Brainwood D,
Kashtan C,
Gubler MC and
Turner AN
(1998)
Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Kidney International
53:
762–766.
|
|
|
Bredrup C,
Matejas V,
Barrow M et al.
(2008)
Ophthalmological aspects of Pierson syndrome.
American Journal of Ophthalmology
146:
602–611.
|
|
|
Cheong HI,
Kashtan CE,
Kim Y,
Kleppel MM and
Michael AF
(1994)
Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome.
Laboratory Investigation
70:
553–557.
|
|
|
Choi HJ,
Lee BH,
Kang JH et al.
(2008)
Variable phenotype of Pierson syndrome.
Pediatric Nephrology
23:
243–249.
|
|
|
Clare NM,
Montiel MM,
Lifschitz MD et al.
(1979)
Alport's syndrome associated with macrothrombocytopenic thrombocytopenia.
American Journal of Clinical Pathology
72:
111–117.
|
|
|
Del Pozo E and
Lapp H
(1970)
Ultrastructure of the kidney in the nephropathy of the Nail–Patella syndrome.
American Journal of Clinical Pathology
54:
845–851.
|
|
|
Dreyer SD,
Zhou G,
Baldini A et al.
(1998)
Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in Nail–Patella syndrome.
Nature Genetics
19:
47–50.
|
|
|
Epstein CJ,
Sahud MA,
Piel CF et al.
(1972)
Hereditary macrothrombocytopenia, nephritis and deafness.
American Journal of Medicine
52:
299–310.
|
|
|
Ghiggeri GM,
Caridi G,
Magrini U et al.
(2003)
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).
American Journal of Kidney Diseases
41:
95–104.
|
|
|
Gross O and
Kashtan CE
(2009)
Treatment of Alport syndrome: beyond animal models.
Kidney International
76:
599–603.
|
|
|
Hamlington JD,
Jones C and
McIntosh I
(2001)
Twenty-two novel LMX1B mutations identified in Nail–Patella syndrome (NPS) patients.
Human Mutation
18:
458.
|
|
|
Hasselbacher K,
Wiggins RC,
Matejas V et al.
(2006)
Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders.
Kidney International
70:
1008–1012.
|
|
|
Hawkins CF and
So E
(1950)
Renal dysplasia in a family with multiple hereditary abnormalities including iliac horns.
Lancet
I:
803–808.
|
|
|
Heath KE,
Campos-Barros A,
Toren A et al.
(2001)
Nonmuscle mysoin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May–Hegglin anomaly and Fechtner, Sebastian, Epstein and Alport-like syndromes.
American Journal of Human Genetics
69:
1033–1045.
|
|
|
Heidet L,
Bongers EM,
Sich M et al.
(2003)
In vivo expression of putative LMX1B targets in Nail–Patella syndrome kidneys.
American Journal of Pathology
163:
145–155.
|
|
|
Heidet L,
Cohen-Solal L,
Boye E et al.
(1997)
Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.
Cytogenetics and Cell Genetics
78:
240–246.
|
|
|
Hoyer JR,
Michael AF and
Vernier RL
(1972)
Renal disease in Nail–Patella syndrome: clinical and morphologic studies.
Kidney International
2:
231–238.
|
|
|
Jais JP,
Knebelmann B,
Giatras I et al.
(2003)
X-linked Alport syndrome: natural history and genotype–phenotype correlations in girls and women belonging to to 195 families: a ‘European Community Alport Syndrome Concerted Action’ study.
Journal of the American Society of Nephrology
14:
2603–2610.
|
|
|
Jais JP,
Knebelmann B,
Giatras I et al.
(2000)
X-linked Alport syndrome: natural history in 195 families and genotype–phenotype correlations in males.
Journal of the American Society of Nephrology
11:
649–657.
|
|
|
Jarad G,
Cunningham J,
Shaw AS and
Miner JH
(2006)
Proteinuria precedes podocyte abnormalities in Lamb2–/– mice, implicating the glomerular basement membrane as an albumin barrier.
Journal of Clinical Investigations
116:
2272–2279.
|
|
|
Kagan M,
Cohen AH,
Matejas V,
Vlangos C and
Zenker M
(2008)
A milder variant of Pierson syndrome.
Pediatric Nephrology
23:
323–327.
|
|
|
Kalluri R,
Shield CF,
Todd P,
Hudson BG and
Neilson EG
(1997)
Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.
Journal of Clinical Investigations
99:
2470–2478.
|
|
|
Kashtan CE
(2006)
Renal transplantation in patients with Alport syndrome.
Pediatric Transplantations
10:
651–657.
|
|
|
Kashtan CE and
Kim Y
(1992)
Distribution of the 1 and 2 chains of collagen IV and of collagens V and VI in Alport syndrome.
Kidney International
42:
115–126.
|
|
|
Kashtan CE,
Kim Y,
Lees GE et al.
(2001)
Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent.
Journal of the American Society of Nephrology
12:
252–260.
|
|
|
Knoers NV,
Bongers EM,
van Beersum SE et al.
(2000)
Nail–Patella syndrome: identification of mutations in the LMX1B gene in Dutch families.
Journal of the American Society of Nephrology
11:
1762–1766.
|
|
|
Kunishima S,
Matsushita T,
Kojima T et al.
(2001)
Identification of six novel MYH9 mutations and genotype–phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
Journal of Human Genetics
46:
722–729.
|
|
|
Lalwani AK,
Goldstein JA,
Kelley MJ et al.
(2000)
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9.
American Journal of Human Genetics
67:
1121–1128.
|
|
|
Lemley KV
(2009)
Kidney disease in Nail–Patella syndrome.
Pediatric Nephrology
24:
2345–2354.
|
|
|
Longo I,
Porcedda P,
Mari F et al.
(2002)
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Kidney International
61:
1947–1956.
|
|
|
Looij BJ,
te Slaa RL,
Hogewind BL and
van de Kamp JJ
(1988)
Genetic counseling in hereditary osteo-onychodysplasia (HOOD, Nail–Patella syndrome) with nephropathy.
Journal of Medical Genetics
25:
682–686.
|
|
|
Marigo V,
Nigro A,
Pecci A et al.
(2004)
Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.
Genomics
83:
1125–1133.
|
|
|
Maselli RA,
Ng JJ,
Anderson JA et al.
(2009)
Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.
Journal of Medical Genetics
46:
203–208.
|
|
|
Matthews JM,
Bhati M,
Craig VJ et al.
(2008)
Competition between LIM-binding domains.
Biochemical Society Transactions
36:
1393–1397.
|
|
|
Meehan DT,
Delimont D,
Cheung L et al.
(2009)
Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
Kidney International
76:
968–976.
|
|
|
Merchant SN,
Burgess BJ,
Adams JC et al.
(2004)
Temporal bone histopathology in Alport syndrome.
Laryngoscope
114:
1609–1618.
|
|
|
Miner JH and
Sanes JR
(1994)
Collagen IV 3, 4 and 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches.
Journal of Cell Biology
127:
879–891.
|
|
|
Moxey-Mims MM,
Young G,
Silverman A et al.
(1999)
End-stage renal disease in two pediatric patients with Fechtner syndrome.
Pediatric Nephrology
13:
782–786.
|
|
|
Naito I,
Nomura S,
Inoue S et al.
(1997)
Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome.
Journal of Clinical Pathology
50:
919–922.
|
|
|
Noakes PG,
Miner JH,
Gautam M et al.
(1995)
The renal glomerulus of mice lacking s-laminin/laminin 2: nephrosis despite molecular compensation by laminin 1.
Nature Genetics
10:
400–406.
|
|
|
Ohkubo S,
Takeda H,
Higashide T et al.
(2003)
Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome.
Archives of Ophthalmology
121:
846–850.
|
|
|
Parsa KP,
Lee DBN,
Zamboni L and
Glassock RJ
(1976)
Hereditary nephritis, deafness and abnormal thrombopoiesis: study of a new kindred.
American Journal of Medicine
60:
665–671.
|
|
|
Pecci A,
Panza E,
De Rocco D et al.
(2010)
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype.
European Journal of Haematology
84:
291–297.
|
|
|
Pecci A,
Panza E,
Pujol-Moix N et al.
(2008)
Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
Human Mutation
29:
409–417.
|
|
|
Peterson LC,
Rao KV,
Crosson JT and
White JG
(1985)
Fechtner syndrome: a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopathia.
Blood
65:
397–406.
|
|
|
Pierson M,
Cordier J,
Hervouuet F and
Rauber G
(1963)
An unusual congential and familial congenital malformative combination involving the eye and kidney.
Journal of Human Genetics
12:
184–213.
|
|
|
Plaisier E,
Gribouval O,
Alamowitch S et al.
(2007)
COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.
New England Journal of Medicine
357:
2687–2695.
|
|
|
Pochet JM,
Bobrie G,
Landais P,
Goldfarb B and
Grunfeld J-P
(1989)
Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance.
Nephrology Dialysis Transplantation
4:
1016–1021.
|
|
|
Rana K,
Wang YY,
Buzza M et al.
(2005)
The genetics of thin basement membrane nephropathy.
Seminars in Nephrology
25:
163–170.
|
|
|
Rao VH,
Lees GH,
Kashtan CE et al.
(2003)
Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
Kidney International
63:
1736–1748.
|
|
|
Rheault MN,
Kren SM,
Hartich LA et al.
(2010)
X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome.
Nephrology Dialysis Transplantation
25:
764–769.
|
|
|
Savige J and
Colville D
(2009)
Ocular features aid the diagnosis of Alport syndrome.
Nature Reviews Nephrology
5:
356–360.
|
|
|
Sekine T,
Konno M,
Sasaki S et al.
(2010)
Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.
Kidney International
78:
207–214.
|
|
|
Seri M,
Pecci A,
Di Bari F et al.
(2003)
MYH9-related disease: May–Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
Medicine (Baltimore)
82:
203–215.
|
|
|
Silverman ME,
Goodman RM and
Cuppage FE
(1967)
The Nail–Patella syndrome. Clinical findings and ultrastructural observations in the kidney.
Archives of Internal Medicine
120:
68–74.
|
|
|
Sutcliffe NP,
Cashman SJ,
Savage CO,
Fox JG and
Boulton-Jones JM
(1989)
Variability of the antigenicity of the glomerular basement membrane in Nail–Patella syndrome.
Nephrology Dialysis Transplantation
4:
262–265.
|
|
|
Sweeney E,
Fryer A,
Mountford R,
Green A and
Mcintosh I
(2003)
Nail–Patella syndrome: review of the phenotype aided by developmental biology.
Journal of Medical Genetics
40:
153–162.
|
|
|
Thielen BK,
Barker DF,
Nelson RD et al.
(2003)
Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
Human Mutation
22:
419.
|
|
|
Turi S,
Kobor J,
Erdos A et al.
(1992)
Hereditary nephritis, platelet disorders and deafness – Epstein's syndrome.
Pediatric Nephrology
6:
38–43.
|
|
|
VanDeVoorde R,
Witte D,
Kogan J and
Goebel J
(2006)
Pierson syndrome: a novel cause of congenital nephrotic syndrome.
Pediatrics
118:
e501–e505.
|
|
|
Vinge L,
Lees GE,
Nielsen R et al.
(2010)
The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney.
Nephrology Dialysis Transplantation
25:
2458–2467.
|
|
|
Vitelli F,
Piccini M,
Caroli F et al.
(1999)
Identification and characterization of a highly conserved protein absent in the Alport syndrome (A), mental retardation (M), midface hypoplasia (M), and elliptocytosis (E) contiguous gene deletion syndrome.
Genomics
55:
335–340.
|
|
|
Voskarides K,
Damianou L,
Neocleous V et al.
(2007)
COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.
Journal of the American Society of Nephrology
18:
3004–3016.
|
|
|
Witzgall R
(2008)
How are podocytes affected in Nail–Patella syndrome?
Pediatric Nephrology
23:
1017–1020.
|
|
|
Zehnder AF,
Adams JC,
Santi PA et al.
(2005)
Distribution of type IV collagen in the cochlea in Alport syndrome.
Archives of Otolaryngology and Head Neck Surgery
131:
1007–1013.
|
|
|
Zenker M,
Aigner T,
Wendler O et al.
(2004a)
Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities.
Human Molecular Genetics
13:
2625–2632.
|
|
|
Zenker M,
Tralau T,
Lennert T et al.
(2004b)
Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome.
American Journal of Medical Genetics A
130A:
138–145.
|
|
|
Zhao D,
Ding J,
Wang F et al.
(2010)
The first Chinese Pierson syndrome with novel mutations in LAMB2.
Nephrology Dialysis Transplantation
25:
776–778.
|
| Further Reading |
|
|
Gubler MC
(2008)
Inherited diseases of the glomerular basement membrane.
Nature Clinical Practice Nephrology
4:
24–37.
|
|
|
book
Kashtan CE
(2011)
"Hereditary nephritis (Alport syndrome)".
In: Rose BD (ed.)
UpToDate.
MA: Wellesley.
|
|
|
book
Kashtan CE
(2011)
"Thin basement membrane disease (benign familial hematuria)".
In: Rose BD (ed.)
UpToDate.
MA: Wellesley.
|
|
|
book
Kashtan CE
(2011)
"Collagen IV-related nephropathies (Alport syndrome and thin basement membrane nephropathy)".
In: Pagon RA,
Bird TD,
Dolan CR et al. (eds)
GeneReviews [www.genereviews.org].
Seattle: University of Washington.
|
|
|
Miner JH
(2011)
Glomerular basement membrane composition and the filtration barrier.
Pediatric Nephrology
26:
1413–1417.
|
|
|
Miner JH
(2011)
Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane.
Organogenesis
7:
75–82.
|
|
|
Pedchenko V,
Bondar O,
Fogo AB et al.
(2010)
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
New England Journal of Medicine
363:
343–354.
|
